| Tag | Content |
|---|
EnhancerAtlas ID | HS053-26992 |
Organism | Homo sapiens |
Tissue/cell | Foreskin_keratinocyte |
Coordinate | chr3:49425090-49427110 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr3:49425428-49425449 | GATGGCTTTCTCTTTTTTTTT | + | 6.24 | | TBXT | MA0009.2 | chr3:49426057-49426073 | TCTCACATTTGTGTGA | - | 6.11 | | TBXT | MA0009.2 | chr3:49426057-49426073 | TCTCACATTTGTGTGA | + | 6 | | Zfx | MA0146.2 | chr3:49426534-49426548 | GAGGCCGAGGCGGG | - | 6.01 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_11376 | chr3:49424884-49427055 | CD20 | | SE_18986 | chr3:49425310-49426676 | CD4p_CD25-_Il17-_PMAstim_Th |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH03I049387 | chr3 | 49425171 | 49425390 |
|
Enhancer Sequence | TGGTGTGAAC CCGGGAGCAG AGGTTGCAGT GAGATCACAC CACTGCACCC CAGCCCGGGG 60
GACAGAGCGA GACTCCAGGT CTCAAAAAAA AAAAACAAAA AAAAAAACCC TATTATGTTT 120
GTTTTCTATG CTTTTATGAT GTTTTTGCAT ACATTTCTTT TAGATGTGTG TATCTTTTTT 180
CTGTACACAC CAGAGGAAGA AATAATAACA ATGTCACATA TGTTTGAGTC ACTCTGAAAT 240
CATCAACTCT TGGTTCTTTG GTTCTAGCAT GTCTTACACC TGTTTACTCT TACTGTTTTA 300
ATGTCTGTTT ACTCATTACA GATGATGTCA AGGAAGGGGA TGGCTTTCTC TTTTTTTTTT 360
TTTCCTGGAG ACAAGGTCTC ACTCTGTTGC CCAGGCTGGA GTGCAGTGCT GTCATCAAGG 420
CTCACTGCAG CGTCAAACTC CTGGGCTCAG GTGACCCTCC CACCTCAGCT TCCCGAGTAG 480
CTGGGACTAT AGGTGTGTGC CACCATTCCC GACTAAATTT TTTTCTATTT GTGTGGGTGT 540
GTGTGTGGAG ACGGGGTTTT GCCATGTTGC CCAGGCTGGT CTCAAACTCC TGGGCTCAGT 600
GATGAACTCC TGGGCTTAAG TGACCCACCC GCCTCTGTCT TCCAAAGTGG TGGGATTATA 660
ATAGGTGGAG CCATGACATC CAGCCAGCTG TGGCTTTCTG AGCTTTAGGG AGCTCTGCTA 720
TAGAAAGAAT GATAGGTGAA GGCCAGTCCT TTTCACACTT TACAAGTCAA AGTGATTTCC 780
TGGGATAACT ATAGCTCATC TGCATTGCTG CCTGCCTTGC TTATCTGGGT GCTGAGTGTG 840
GGAGTGGTGT GTCCATCATA TGTTCTTCAG ATGCTACAGT GGCTACTGAC TATGCTTCAG 900
TAGGTAAATT AAAACCATGC ATTAATGAGC AACTCTCCGC ATTTCACATA GCAGTCTTTG 960
GTAATTTTCT CACATTTGTG TGACCATGAT GCTTACTCAC ATTTGTCTGG ACAACTTCCT 1020
GAAGGCCTTC TGGAGCTGTT CAATGGGCCA GCCCACTAAT AACTAATTTA GTATCTCACA 1080
TTTTGAAATG TGGAGCTGTT CAATGGCCAG CCTACTAATG ACTAATATCT CACACTTTGA 1140
AATCTTTGTT CATTAGCTTT TAATTAACAA AACAATCCTA TCTAAGCTAC ATATCTAACC 1200
ATGTGTTATA GCCATACAGT GGAGTACTAC TCAGCAACAA TAAGGAACGA AGTACAGTAC 1260
TGTACTGAAA CATGCTACAA CATGGATGAA TCTTGAAAAT ACTATGCTCA GTAAAAGAAA 1320
CCAGTCACAA AGAACCACAT GTTTCATACC ATATTTGTAT GAAATATCCA GAATAGGTAA 1380
ATCTACAGAG ACAGAAAGCA GCTGCTGGGC GTGGTAGCTC ACGCCTGTAA TCCCAGCACT 1440
TTGGGAGGCC GAGGCGGGTG GAACACCTGA AGTCAGGAGT TCAAGACCAA CCTGGCCAAC 1500
CTGGTGAAAC CCCATCTCTA CAAAAATACA AAAAAAAAAA TCAGCCAGGC CTGGTGGCGT 1560
CCACCTGTAA TCCCAGCTAC TCGGGGGGCT GAGCTTGCAG TGAGTGAAGA TTGTGACATT 1620
GCGCTCCAGC CTGGGCGACA AAGCGAGACT CCATCTCCAA AAAAAAAAAG GAGCATAGTG 1680
GTTGCTTAGG GATGAGGCTA ATAGGGACTC TCCAGGCAGA ACCCAAGAAG AATGTGTGAG 1740
CTTAGTTTGG GGTTCAGCAG CACTTGCTGA GAGGAACCTG CTGTGCTTCT CAGATTCCCT 1800
AGGCCCATCT TGGAAGGACT TAACTCCAGA ACAGGTTCTG AGCGGCAGGT CTATTTCCAG 1860
CCACATGTCA TTAATAGACT AATTCCTCTG CTGAAAAAGA GTCATGACAC TTCTTACTTC 1920
TTACAGCAGT GAACAGACTC AGGAGCTCTG TTCTGTCCAG AATTCCAATA GCTAACAACT 1980
TACAATAAAT AAAAGTTACA GAAGCCGGGC GCGGTGGCTT 2020
|
